Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label sporadic. Show all posts
Showing posts with label sporadic. Show all posts
Sunday, January 29, 2012

open access: The origin of ovarian cancer (including references to familial/non-familial ovarian cancer/inclusion cysts...)

›
"According to Hamilton, 1 the concept that epithelial ovarian cancers arise from ovarian surface epithelial (OSE) cells was proposed...
Tuesday, March 08, 2011

worth reading - Medical News: SGO: PARP Inhibitor Active in Ovarian Cancer - in Meeting Coverage, SGO from MedPage Today

›
......"Antitumor activity was observed in heavily pretreated BRCA1 and BRCA2 mutation carriers, and preliminary antitumor activity was...
Wednesday, January 26, 2011

free full access: Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients — Ann Oncol

›
Tuesday, August 03, 2010

PARP inhibition: targeting the Achilles' heel of DNA repair..PARP inhibition: targeting the Achilles' heel of DNA repair to treat germline and sporadic ovarian cancers

›
Tuesday, May 25, 2010

Genetic/Familial high-risk assessment: breast and ... [J Natl Compr Canc Netw. 2010] - PubMed result

›
Abstract Overview All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth ...
Friday, May 07, 2010

Clinical Significance of Microsatellite Instability in Sporadic Epithelial Ovarian Tumors

›
Abstract: CONCLUSION: MSI was infrequent in ovarian tumors, including both borderline and malignant tumors. MSI was found to be uncommon ...
Monday, April 26, 2010

media item: Study Makes Strides in Understanding Ovarian Cancer (cysts/BRCA/sporadic)

›
Important: see post April 26th -  full free access:  PLOS One: Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcin...
Wednesday, April 21, 2010

Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype

›
Note: see abstract for further information Results: Seventy-nine patients with EOC/PPC and germline BRCA1/2 mutations were identified. F...
Saturday, March 20, 2010

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

›
Thursday, January 21, 2010

Jan 2009 full free access - Development of PARP inhibitors in oncology; Expert Opinion on Investigational Drugs + Expert Opinion

›
Note: highly technical but worth reviewing (BRCAness, sporadic, specific therapies (combination/single agent/+radiotherapy), those in clini...